Journal
RHEUMATOLOGY
Volume 60, Issue 7, Pages 3072-3087Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/key438
Keywords
Sjogren's syndrome; chemokines; inflammasome; IL-1 cytokine family
Categories
Funding
- Hellenic Rheumatology Association Grant
Ask authors/readers for more resources
In pSS, chemokines and cytokines play crucial roles in orchestrating immunopathology through regulating a complex network of interacting inflammatory cells. The emerging roles of novel chemotactic and non-chemotactic mediators are highlighted in controlling pathogenic processes, such as promoting B cell hyperactivity and ectopic lymphoid structures formation.
In primary SS (pSS), chemokines and cytokines orchestrate immunopathology driven by a complex network of interacting inflammatory cells. In recent years, the importance of chemotactic and non-chemotactic cytokines that control function, movement and placing of all cells within the inflamed exocrine glands and directing immunopathology has become increasingly clear. This paper reviews the current knowledge on chemokines and focuses on the emerging roles of novel chemotactic and non-chemotactic mediators in pSS. It highlights their contribution to pathogenic processes such as B cell hyperactivity and the formation of ectopic lymphoid structures. To this end, the role of acquired (CXCR5/CCR9 Th-cell-mediated) and innate (inflammasome/IL-1/IL-18-mediated) pathways in steering immunopathology is discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available